ValuationViz

HRMY fund manager activity

Harmony Biosciences Holdings, Inc · Nasdaq. Reported by 3 tracked fund managers in their 13F filings, Q3 2022 to Q2 2026.

Q2 2025

ManagerActivitySharesValue% of portfolioFiled
Joel Greenblatt - Gotham Asset ManagementAdded39,707$1,254,7410.01%Aug 14, 2025

Q1 2025

ManagerActivitySharesValue% of portfolioFiled
Joel Greenblatt - Gotham Asset ManagementTrimmed23,163$768,7800.01%May 15, 2025

Newer quarters · Older quarters